These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34236019)

  • 41. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Latent Class Analysis for the Diagnosis of Clostridioides difficile Infection.
    Doolan CP; Louie T; Lata C; Larios OE; Stokes W; Kim J; Brown K; Beck P; Deardon R; Pillai DR
    Clin Infect Dis; 2021 Nov; 73(9):e2673-e2679. PubMed ID: 33053174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
    Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
    J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immediate impact of healthcare-facility-onset Clostridium difficile laboratory-identified events reporting methodology change on standardized infection ratios.
    Figueroa Castro CE; Palen L; Johnson C; Graham MB; Letzer D; Ledeboer N; Buchan B; Block T; Seliger H; Singh S; Behrens E; Huerta S; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1484-1486. PubMed ID: 30348236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
    DiPersio JR; Varga FJ; Conwell DL; Kraft JA; Kozak KJ; Willis DH
    J Clin Microbiol; 1991 Dec; 29(12):2724-30. PubMed ID: 1757540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory Diagnosis of
    Chung HS; Park JS; Shin BM
    Ann Lab Med; 2019 May; 39(3):317-321. PubMed ID: 30623624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for
    Johnson LK; Munoz-Price S; Patel PB; Patel A; Stein DJ; Yarur AJ
    Ann Gastroenterol; 2022; 35(2):135-139. PubMed ID: 35479586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does the handling time of unrefrigerated human fecal specimens impact the detection of Clostridium difficile toxins in a hospital setting?
    Modi C; DePasquale JR; Nguyen NQ; Malinowski JE; Perez G
    Indian J Gastroenterol; 2010 Jul; 29(4):157-61. PubMed ID: 20740339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Statewide Prevention and Reduction of
    Rock C; Perlmutter R; Blythe D; Bork J; Claeys K; Cosgrove SE; Dzintars K; Fabre V; Harris AD; Heil E; Hsu YJ; Keller S; Maragakis LL; Milstone AM; Morgan DJ; Dullabh P; Ubri PS; Rotondo C; Brooks R; Leekha S
    BMJ Qual Saf; 2022 Feb; 31(2):153-162. PubMed ID: 34887357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.